Triazolopyrimidines identified as reversible myeloperoxidase inhibitors
三唑并嘧啶类化合物被鉴定为可逆性髓过氧化物酶抑制剂
期刊:Medchemcomm
影响因子:
doi:10.1039/c7md00268h
Duclos, Franck; Abell, Lynn M; Harden, David G; Pike, Kristen; Nowak, Kimberly; Locke, Gregory A; Duke, Gerald J; Liu, Xiaoqin; Fernando, Gayani; Shaw, Scott A; Vokits, Benjamin P; Wurtz, Nicholas R; Viet, Andrew; Valente, Meriah N; Stachura, Sylwia; Sleph, Paul; Khan, Javed A; Gao, Ji; Dongre, Ashok R; Zhao, Lei; Wexler, Ruth R; Gordon, David A; Kick, Ellen K